October 11, 2016 / 9:52 PM / in a year

BRIEF-Acasti Pharma Q2 loss per share $0.22

Oct 11 (Reuters) - Acasti Pharma Inc

* reports second quarter 2017 financial results

* Qtrly loss per share $0.22

* if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern

* Management has reasonable expectation that corporation will be able to raise additional funds Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below